Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
Qiqing Yang, Bin Wang, Qinghui Zheng, et al.
Advanced Science (2023) Vol. 10, Iss. 15
Open Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

Precision unveiled: Synergistic genomic landscapes in breast cancer—Integrating single‐cell analysis and decoding drug toxicity for elite prognostication and tailored therapeutics
Cheng‐Lu Jiang, Shengke Zhang, Lai Jiang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3448-3472
Closed Access | Times Cited: 16
Approach to the diagnosis and management of dysbiosis
Kannayiram Alagiakrishnan, Joao Morgadinho, Tyler Halverson
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 7
Exploring the gut microbiota and its potential as a biomarker in gliomas
Dana Aljarrah, Naima Chalour, Amine Zorgani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116420-116420
Open Access | Times Cited: 6
Targeting the gut microbiota to enhance the antitumor efficacy and attenuate the toxicity of CAR-T cell therapy: a new hope?
Pengfei Zhang, Dan Xie
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Tumor microenvironment as a complex milieu driving cancer progression: a mini review
Zhengrui Li, Jing Li, Xiaolei Bai, et al.
Clinical & Translational Oncology (2024)
Open Access | Times Cited: 6
Oncomicrobial vaccines mitigate tumor progression via precisely targeting oncomicrobes in mice
Yudan Mao, Yan Li, Xianzun Xiao, et al.
Protein & Cell (2025)
Open Access
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Unveiling the Interplay Between the Human Microbiome and Gastric Cancer: A Review of the Complex Relationships and Therapeutic Avenues
Jenan Al‐Matouq, Hawra Al-Ghafli, Noura N. Alibrahim, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 226-226
Open Access
Microbial molecules, metabolites, and malignancy
Ryan M. Thomas
Neoplasia (2025) Vol. 60, pp. 101128-101128
Closed Access
Interactions between the tumor microbiota and breast cancer
Hua Guo
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access
Fasting-mimicking diet-enrichedBifidobacterium pseudolongumsuppresses colorectal cancer by inducing memory CD8+T cells
Ke Nan, Ziwen Zhong, Ying Yue, et al.
Gut (2025), pp. gutjnl-333020
Closed Access
Synergistic Interactions Between Probiotics and Anticancer Drugs: Mechanisms, Benefits, and Challenges
Babak Pezeshki, Hussein T. Abdulabbas, Asma M. Alturki, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access
Gut microbiota derived DCA enhances FOLFOX efficacy via Ugt1a6b mediated enterohepatic circulation in colon cancer
Fang Qian, Xiaoying Hou, Limei Fan, et al.
Pharmacological Research (2025), pp. 107636-107636
Open Access
Modulation of the Neuro–Cancer Connection by Metabolites of Gut Microbiota
Alice Njolke Mafe, Dietrich Büsselberg
Biomolecules (2025) Vol. 15, Iss. 2, pp. 270-270
Open Access
Exploring the causal associations of the gut microbiota and plasma metabolites with ovarian cancer: an approach of mendelian randomization analysis combined with network pharmacology and molecular docking
Junfeng Guo, Chen Wang, He Li, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access
A comparison between full-length 16S rRNA Oxford nanopore sequencing and Illumina V3-V4 16S rRNA sequencing in head and neck cancer tissues
Kenny Yeo, James Connell, George Bouras, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 6
Open Access | Times Cited: 5
Akkermansia muciniphila-derived pentadecanoic acid enhances oxaliplatin sensitivity in gastric cancer by modulating glycolysis
Qixuan Xu, Jingwang Gao, Ruiyang Zhao, et al.
Pharmacological Research (2024) Vol. 206, pp. 107278-107278
Open Access | Times Cited: 5
Ameliorative effect of an acidic polysaccharide from Phellinus linteus on ulcerative colitis in a DSS-induced mouse model
Jutuan Hu, Yuxia Mei, Heng Zhang, et al.
International Journal of Biological Macromolecules (2024) Vol. 265, pp. 130959-130959
Closed Access | Times Cited: 4
Multi-omics-based investigation of Bifidobacterium’s inhibitory effect on glioma: regulation of tumor and gut microbiota, and MEK/ERK cascade
Huali Fan, Yuhan Wang, Mingyu Han, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4
Escherichia coli on colorectal cancer: A two‐edged sword
Jian Chu, Wu Yinhang, Jing Zhuang, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 10
Open Access | Times Cited: 4
Hypoxia-associated autophagy flux dysregulation in human cancers
Jiding Fu, Jie Lin, Zili Dai, et al.
Cancer Letters (2024) Vol. 590, pp. 216823-216823
Closed Access | Times Cited: 3
Targeting gut microbiota for immunotherapy of diseases
Yajie Yu, Xiaodong Liu, Cai Liao, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 8, pp. 2429-2439
Closed Access | Times Cited: 3
Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria
Guofeng Ji, Jingjing Zhao, Xinghui Si, et al.
Advanced Drug Delivery Reviews (2024) Vol. 211, pp. 115345-115345
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top